<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EBOLAWEB &#187; Biomedicine/Clinical &#124; EBOLAWEB</title>
	<atom:link href="http://www.ebolaweb.org/?cat=8&#038;feed=rss2" rel="self" type="application/rss+xml" />
	<link>http://www.ebolaweb.org</link>
	<description>Selected papers on Ebola Virus outbreak and its Responses</description>
	<lastBuildDate>Tue, 16 Dec 2014 11:13:27 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.0.24</generator>
	<item>
		<title>Appel à contributions pour un numéro spécial « Autour du virus Ebola »</title>
		<link>http://www.ebolaweb.org/?p=394</link>
		<comments>http://www.ebolaweb.org/?p=394#comments</comments>
		<pubDate>Wed, 10 Dec 2014 15:44:06 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[French]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[RDC]]></category>
		<category><![CDATA[Senegal]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[Spain]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[Anne Marie Moulin]]></category>
		<category><![CDATA[Anthropologie et Santé]]></category>
		<category><![CDATA[Ebola]]></category>
		<category><![CDATA[épidémie]]></category>
		<category><![CDATA[prévention]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=394</guid>
		<description><![CDATA[La revue Anthropologie et Santé lance un appel à contribution en vue d&#8217;un numéro spécial &#8220;Autour du virus Ebola&#8221;, coordonné par Anne Marie Moulin. Texte de l&#8217;appel Le virus de la fièvre hémorragique Ebola a concerné d’abord l’Afrique de l’Ouest et l’Afrique centrale, où des anthropologues escortent d’ores et déjà &#8230;]]></description>
				<content:encoded><![CDATA[<p>La revue Anthropologie et Santé lance un appel à contribution en vue d&#8217;un numéro spécial &#8220;Autour du virus Ebola&#8221;, coordonné par Anne Marie Moulin.</p>
<p><a href="http://amades.hypotheses.org/5041" target="_blank"><img class="aligncenter wp-image-909 size-full" src="http://chiasm.hypotheses.org/files/2014/12/BandeauAS.png" alt="" width="896" height="146" /></a></p>
<h4>Texte de l&#8217;appel</h4>
<p>Le virus de la fièvre hémorragique Ebola a concerné d’abord l’Afrique de l’Ouest et l’Afrique centrale, où des anthropologues escortent d’ores et déjà les équipes sur le terrain. Mais la menace de la diffusion de l’épidémie a suscité une alerte à l’échelon mondial, qui relève également de l’observation anthropologique. Si le matériau anthropologique sur l’épidémie de 2014 est encore restreint, les études sur les épidémies précédentes, restées locales, ont montré que les mesures prises pour isoler les malades et empêcher la contagion doivent être élaborées et mûrement pesées, pour éviter, en ignorant le contexte, d’aggraver le désordre social lié au phénomène épidémique, si bien décrit par Thucydide au moment de la « peste » d’Athènes (IVe siècle av J-C).</p>
<p>À des investigations ethnographiques des épidémies d’Ebola, depuis la première en date de 1996 au Zaïre, le numéro spécial souhaite associer des contributions inspirées par l’anthropologie historique, s’appuyant sur des comparaisons et renouvelant la typologie des comportements individuels et collectifs face aux épidémies.</p>
<p>Il existe une très abondante littérature, romanesque et scientifique, sur les épidémies, notamment sur les grandes pandémies de peste et de choléra. L’ensemble de mesures récemment prises par les autorités nationales et internationales présente des analogies évidentes avec les dispositifs adoptés, du Moyen Age à nos jours, face à la contagion : isolement des malades, délimitation et destruction des foyers, contrôle de la circulation des personnes et des marchandises etc. Pour circonscrire le contenu du numéro et mettre en lumière l’originalité du phénomène Ebola, l’équipe éditrice d’<i>Anthropologie &amp; Santé</i> propose de centrer les études sur les aspects suivants :</p>
<p>&#8211; l’analyse du puzzle scientifique de l’épidémie d’Ebola a mis en évidence en 1996 un virus inconnu jusque-là et pour cette raison appelé émergent, mais les connaissances épidémiologiques restent à certains égards lacunaires ;</p>
<p>&#8211; les mesures sécuritaires prises doivent tenir compte de ces lacunes. Elles doivent donc suivre le principe de précaution tout en s’adaptant à l’évolution rapide des connaissances biomédicales. Elles doivent également s’inspirer des principes éthiques qui ont établi des normes fondées sur le respect de l’autonomie des personnes. Comment concilier ces différents impératifs ? Quel est l’apport de l’anthropologie sur ce sujet?</p>
<p>&#8211; l&#8217;épidémie d&#8217;Ebola et les mesures de prévention contre la contagion ont entraîné, dans la population, des réactions telles que la panique ou la méfiance à l’égard du discours médical sur la maladie, phénomènes sociaux renforcés par le traitement de l&#8217;épidémie dans l&#8217;espace public.</p>
<p>&#8211; le progrès des connaissances biologiques (diagnostic précoce et rapide) épidémiologiques (voies de transmission du virus et moyens de prévention) et thérapeutiques (sérums, vaccins, antibiotiques) devrait permettre une gestion de la crise sanitaire. Cependant, l’épidémie d’Ebola risque, comme le Sida avant elle, de révéler la fragilité croissante des systèmes de santé, en Afrique et hors d’Afrique, l’impréparation des personnels de santé en première ligne devant le risque épidémique collectif et personnel, et l’inadéquation des relais d’information auprès des différents publics. Cette épidémie révèle, de surcroît, des différences notables entre les pays, entre les niveaux de connaissance des maladies épidémiques et de compréhension des moyens préventifs à mettre en œuvre, facilitant déni, agressivité, dénonciation de l’étranger toujours tenu pour responsable du désordre, quelle que soit sa définition.</p>
<p>Pour traiter ces différentes questions, la revue<i> Anthropologie &amp; Santé </i>attend principalement des contributions anthropologiques, mais elle reste également ouverte à d&#8217;autres disciplines, dans la mesure où l&#8217;épidémie d&#8217;Ebola interpelle également les historiens de la biomédecine, les politologues et les éthiciens, ou encore les spécialistes de l’information et de la communication. Elle leur  impose en effet de repenser le partage des responsabilités et de la prise des décisions à tous les niveaux, et les conditions à remplir pour un maintien de la solidarité entre les citoyens et de la confiance placée dans les professionnels de santé.</p>
<p>Tenant compte de la dimension historique du phénomène épidémique et de ses composantes psychosociales, mais prenant aussi toute la mesure de l’originalité du phénomène Ebola d’hier à aujourd’hui, le numéro spécial d’<i>Anthropologie &amp; Santé</i> se positionne résolument, et conformément à la vocation de la revue dans une perspective anthropologique pluridimensionnelle, en particulier historique et politique, indispensable pour les élaborations théoriques comme pour la conduite de la lutte contre la maladie sur le terrain.</p>
<p>Les contributions peuvent prendre la forme d&#8217;articles ethnographiques descriptifs, d&#8217;analyses préliminaires ou abouties, adopter une perspective historique ou comparative… Elles peuvent être accompagnées de documents graphiques, photographiques ou vidéos.</p>
<h4>Calendrier</h4>
<p>Les propositions (titre et résumé ne dépassant pas 1000 signes) sont à adresser par courriel à <i>Anthropologie &amp; Santé</i> (revue) <a href="mailto:redaction@anthropologie-sante.net">redaction@anthropologie-sante.net</a>, avant le 15 janvier 2015. Les articles devront être envoyés avant le 1<sup>er </sup> juin 2015, afin que le numéro puisse paraître en décembre 2015.</p>
<h6>Source</h6>
<h6><a href="http://amades.hypotheses.org/5041" target="_blank">http://amades.hypotheses.org/5041</a></h6>
<h6>Appel à contribution au format PDF</h6>
<h6><a href="http://f-origin.hypotheses.org/wp-content/blogs.dir/11/files/2014/11/AAC-AS-Ebola.pdf" target="_blank">http://f-origin.hypotheses.org/wp-content/blogs.dir/11/files/2014/11/AAC-AS-Ebola.pdf</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=394</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies)</title>
		<link>http://www.ebolaweb.org/?p=385</link>
		<comments>http://www.ebolaweb.org/?p=385#comments</comments>
		<pubDate>Tue, 18 Nov 2014 12:10:17 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[RDC]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[blood transfusion]]></category>
		<category><![CDATA[health authorities]]></category>
		<category><![CDATA[interest in convalescent therapies]]></category>
		<category><![CDATA[plasma]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[ZMapp]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=385</guid>
		<description><![CDATA[Published on who.int, 26 September 2014 The current evidence base: limited data – from 1976 up to now Convalescent therapy was first used for a young woman infected with Ebola in the Democratic Republic of Congo (then Zaire) in 1976 – the year the virus first emerged. The woman was &#8230;]]></description>
				<content:encoded><![CDATA[<p>Published on who.int, 26 September 2014</p>
<blockquote>
<h3 class="section_head1">The current evidence base: limited data – from 1976 up to now</h3>
<p>Convalescent therapy was first used for a young woman infected with Ebola in the Democratic Republic of Congo (then Zaire) in 1976 – the year the virus first emerged. The woman was treated with plasma from a person who survived infection with the closely-related Marburg virus. She had less clinical bleeding than other Ebola patients, but died within days.</p>
<p>During the 1995 Ebola outbreak in Kikwit, Democratic Republic of Congo, whole blood collected from recovered patients was administered to eight patients. Seven of the eight recovered.</p>
<p>&nbsp;</p></blockquote>
<h3 class="section_head1">Technical guidance for experts</h3>
<div class="image_left"><img src="http://www.who.int/entity/csr/resources/publications/ebola/convalescent-treatment-cover.png" alt="" width="130" height="168" /></div>
<p><a href="http://www.who.int/entity/csr/resources/publications/ebola/convalescent-treatment/en/index.html">Guidance document: Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease</a></p>
<p>WHO issued new interim guidance on &#8220;Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion during outbreaks&#8221;. The document is addressed to national health authorities and blood transfusion services.</p>
<p>&nbsp;</p>
<h6>Read the full article</h6>
<h6><a href="http://www.who.int/mediacentre/news/ebola/26-september-2014/en/" target="_blank">http://www.who.int/mediacentre/news/ebola/26-september-2014/en/</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=385</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ebola vaccines, therapies, and diagnostics &#8211; WHO update</title>
		<link>http://www.ebolaweb.org/?p=381</link>
		<comments>http://www.ebolaweb.org/?p=381#comments</comments>
		<pubDate>Tue, 18 Nov 2014 11:58:19 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[RDC]]></category>
		<category><![CDATA[Senegal]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[Convalescent blood and plasma therapies]]></category>
		<category><![CDATA[Ebola vaccines]]></category>
		<category><![CDATA[Ethics working group]]></category>
		<category><![CDATA[medical devices and protective equipment]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[medicines and other health technologies]]></category>
		<category><![CDATA[Potential vaccines]]></category>
		<category><![CDATA[therapies and diagnostics Q&A]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=381</guid>
		<description><![CDATA[Convalescent blood and plasma therapies Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies) 26 September 2014 WHO interim guidelines on use of convalescent whole blood and convalescent plasma 10 September 2014 Potential vaccines, medicines and other health technologies WHO Meeting &#8230;]]></description>
				<content:encoded><![CDATA[<div class="teaser">
<h4>Convalescent blood and plasma therapies</h4>
</div>
<ul class="list_dash">
<li><a href="http://www.who.int/entity/mediacentre/news/ebola/26-september-2014/en/index.html">Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies)</a><br />
<span class="link_info">26 September 2014</span></li>
<li><a class="" href="http://apps.who.int/iris/bitstream/10665/135591/1/WHO_HIS_SDS_2014.8_eng.pdf?ua=1">WHO interim guidelines on use of convalescent whole blood and convalescent plasma</a><br />
<span class="link_info">10 September 2014</span></li>
</ul>
<h4 class="section_head2">Potential vaccines, medicines and other health technologies</h4>
<ul class="list_dash">
<li><a href="http://www.who.int/entity/medicines/ebola-treatment/scientific_tech_meeting/en/index.html">WHO Meeting of the Scientific and Technical Advisory Committee on Ebola Experimental Interventions</a><br />
<span class="link_info">13 November 2014- Briefing note</span></li>
<li><a href="http://www.who.int/entity/medicines/news/AFR_reg_meet/en/index.html">African regulators’ meeting looking to expedite approval of vaccines and therapies for Ebola </a><br />
<span class="link_info">3 &#8211; 7 November, Pretoria, South Africa</span></li>
<li><a href="http://www.who.int/entity/mediacentre/news/releases/2014/ebola-vaccines-production/en/index.html">WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine</a><br />
<span class="link_info">24 October 2014. News release</span></li>
<li><a class="link_media" href="http://www.who.int/entity/diagnostics_laboratory/141002_revised_invitation_to_mx_of_ebola_virus_diagnostics.pdf?ua=1">Invitation to manufacturers of in vitro diagnostics for Ebola<br />
<span class="link_info">pdf, 169kb</span></a><br />
<span class="link_info">Revised version issued 2 October 2014</span></li>
<li><a class="link_media" href="http://www.who.int/entity/medicines/publications/target-product-profile.pdf?ua=1">Target product profile for Zaïre ebolavirus: rapid, simple test to be used in the control of the Ebola outbreak in West Africa<br />
<span class="link_info">pdf, 162kb</span></a><br />
<span class="link_info">3 October 2014</span></li>
<li><a href="http://www.who.int/entity/mediacentre/news/ebola/01-october-2014/en/index.html">Experimental Ebola vaccines</a><br />
<span class="link_info">Ebola situation assessment &#8211; 1 October 2014</span></li>
<li><a href="http://www.who.int/entity/immunization/diseases/ebola/WHO_consultation_ebola_sep2014/en/index.html">WHO consultation on Ebola vaccines</a><br />
<span class="link_info">29-30 September 2014, Geneva, Switzerland</span></li>
<li><a href="http://www.who.int/entity/csr/resources/publications/ebola/ebola-therapies/en/index.html">WHO Consultation on potential Ebola therapies and vaccines</a><br />
<span class="link_info">Meeting summary from 4-5 September Meeting</span></li>
<li><a href="http://www.who.int/entity/mediacentre/events/meetings/2014/ebola-interventions/en/index.html">Consultation on potential Ebola therapies and vaccines</a><br />
<span class="link_info">4-5 September 2014</span></li>
<li><a href="http://www.who.int/entity/csr/resources/publications/ebola/ethical-considerations/en/index.html">Ethical considerations for use of unregistered interventions for Ebola virus disease</a><br />
<span class="link_info">Report of an advisory panel to WHO, 17 August 2014</span></li>
<li><a href="http://www.who.int/entity/csr/disease/ebola/ethics-panel-discussion/en/index.html">Panel discussion on ethical considerations for use of unregistered interventions for Ebola virus disease</a><br />
<span class="link_info">8 August 2014</span></li>
<li><a href="http://www.who.int/entity/mediacentre/news/statements/2014/ethical-review-ebola/en/index.html">WHO to convene ethical review of experimental treatment for Ebola</a><br />
<span class="link_info">6 August 2014</span></li>
</ul>
<h4 class="section_head2">Medicines, medical devices and protective equipment</h4>
<ul class="list_dash">
<li><a href="http://www.who.int/entity/medical_devices/meddev_ebola/en/index.html">Medical devices and protective equipment</a></li>
<li><a class="link_media" href="http://www.who.int/entity/medicines/areas/medicines_list_ebola_07nov.pdf?ua=1">List of essential supportive medicines for Ebola<br />
<span class="link_info">pdf, 61kb</span></a></li>
<li><a href="http://www.who.int/entity/medicines/areas/donations/en/index.html">Donation guidelines</a></li>
</ul>
<h4 class="section_head2">Ethics working group on Ebola</h4>
<ul class="list_dash">
<li><a href="http://www.who.int/entity/medicines/wg_ethics_ebola_interventions/en/index.html">Meeting of the Ethics Working Group on Ebola Interventions</a><br />
<span class="link_info">20 – 21 October 2014, Geneva, Switzerland</span></li>
</ul>
<p>&nbsp;</p>
<h6>Source</h6>
<h6><a href="http://www.who.int/medicines/emp_ebola_section/en/" target="_blank">http://www.who.int/medicines/emp_ebola_section/en/</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=381</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Factors Might Have Led to the Emergence of Ebola in West Africa?</title>
		<link>http://www.ebolaweb.org/?p=369</link>
		<comments>http://www.ebolaweb.org/?p=369#comments</comments>
		<pubDate>Mon, 17 Nov 2014 16:31:48 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[RDC]]></category>
		<category><![CDATA[Senegal]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[bushmeat]]></category>
		<category><![CDATA[Central Africa]]></category>
		<category><![CDATA[early warning systems]]></category>
		<category><![CDATA[Ebola]]></category>
		<category><![CDATA[emerging disease]]></category>
		<category><![CDATA[human behavior]]></category>
		<category><![CDATA[PLOS Neglected Tropical Diseases]]></category>
		<category><![CDATA[public health policy]]></category>
		<category><![CDATA[public health preparedness]]></category>
		<category><![CDATA[West Africa]]></category>
		<category><![CDATA[zoonotic]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=369</guid>
		<description><![CDATA[By PLOS Neglected Tropical Diseases, November 11, 2014 &#160; Abstract An Ebola outbreak of unprecedented scope emerged in West Africa in December 2013 and presently continues unabated in the countries of Guinea, Sierra Leone, and Liberia. Ebola is not new to Africa and outbreaks have been confirmed as far back &#8230;]]></description>
				<content:encoded><![CDATA[<div id="main">By <span class="author vcard"><a class="url fn n" title="View all posts by PLOS Neglected Tropical Diseases" href="http://blogs.plos.org/speakingofmedicine/author/pntds/">PLOS Neglected Tropical Diseases</a></span><span class="meta-prep-author meta-prep">, <span class="entry-date">November 11, 2014</span></span></div>
<p>&nbsp;</p>
<div><strong>Abstract</strong></div>
<div>An Ebola outbreak of unprecedented scope emerged in West Africa in December 2013 and presently continues unabated in the countries of Guinea, Sierra Leone, and Liberia. Ebola is not new to Africa and outbreaks have been confirmed as far back as 1976. The current West African Ebola outbreak is the largest ever recorded and differs dramatically from prior outbreaks in its duration, number of people affected, and geographic extent. The emergence of this deadly disease in West Africa invites many questions, foremost among these: Why now and why in West Africa? Here, we review the sociological, ecological, and environmental drivers that might have influenced the emergence of Ebola in this region of Africa and its spread throughout the region. Containment of the West African Ebola outbreak is the most pressing, immediate need. A comprehensive assessment of the drivers of Ebola emergence and sustained human-to-human transmission is also needed in order to prepare other countries for importation or emergence of this disease.  Such assessment includes identification of country-level protocols and interagency policies for outbreak detection and rapid response, increased understanding of cultural and traditional risk factors within and between nations, delivery of culturally embedded public health education, and regional coordination and collaboration, particularly with governments and health ministries throughout Africa. Public health education is also urgently needed in countries outside of Africa in order to ensure that risk is properly understood and public concerns do not escalate unnecessarily. To prevent future outbreaks, coordinated, multiscale, early warning systems should be developed that make full use of these integrated assessments, partner with local communities in high-risk areas, and provide clearly defined response recommendations specific to the needs of each community.</div>
<p>&nbsp;</p>
<div><strong>Reference</strong></div>
<div>
<div class="csl-bib-body">
<div class="csl-entry">Alexander, K. A., C. E. Sanderson, M. Marathe, B. L. Lewis, C. M. Rivers, J. Shaman, J. M. Drake, et al. “What Factors Might Have Led to the Emergence of Ebola in West Africa?,” 2014. <a href="http://blogs.plos.org/speakingofmedicine/files/2014/11/Alexander-et-al.pdf" target="_blank">http://blogs.plos.org/speakingofmedicine/files/2014/11/Alexander-et-al.pdf</a>.</div>
<div class="csl-entry"></div>
<p class="csl-entry">
<h6 class="csl-entry">Read the full article</h6>
<p class="csl-entry"><a href="http://blogs.plos.org/speakingofmedicine/2014/11/11/factors-might-led-emergence-ebola-west-africa/" target="_blank">http://blogs.plos.org/speakingofmedicine/2014/11/11/factors-might-led-emergence-ebola-west-africa/</a></p>
<p class="csl-entry">
<div class="csl-entry"><strong>PDF file</strong></div>
<div class="csl-entry"><strong><a href="http://blogs.plos.org/speakingofmedicine/files/2014/11/Alexanderetal.pdf" target="_blank">http://blogs.plos.org/speakingofmedicine/files/2014/11/Alexanderetal.pdf</a></strong></div>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=369</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quand l’homme favorise les épidémies</title>
		<link>http://www.ebolaweb.org/?p=360</link>
		<comments>http://www.ebolaweb.org/?p=360#comments</comments>
		<pubDate>Mon, 17 Nov 2014 14:20:58 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[Countries]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[French]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[Chikungunya]]></category>
		<category><![CDATA[crise sanitaire]]></category>
		<category><![CDATA[Ebola]]></category>
		<category><![CDATA[François Renaud]]></category>
		<category><![CDATA[grippe aviaire]]></category>
		<category><![CDATA[SRAS]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=360</guid>
		<description><![CDATA[Publié sur CNRS Le Journal, le 23 octobre 2014, par Laure Cailloce Bactéries, virus et parasites ont toujours existé dans le grand livre du vivant. L’essor de l’élevage industriel, du commerce mondial, mais aussi l&#8217;entrée dans de nouveaux écosystèmes, comme pour Ebola, ont favorisé l’émergence de nouvelles niches pour ces &#8230;]]></description>
				<content:encoded><![CDATA[<p>Publié sur CNRS Le Journal, le 23 octobre 2014, par <a class="node node-107 entityreference" href="https://lejournal.cnrs.fr/auteurs/laure-cailloce">Laure Cailloce</a></p>
<blockquote><p>Bactéries, virus et parasites ont toujours existé dans le grand livre du vivant. L’essor de l’élevage industriel, du commerce mondial, mais aussi l&#8217;entrée dans de nouveaux écosystèmes, comme pour Ebola, ont favorisé l’émergence de nouvelles niches pour ces pathogènes. Explications avec le biologiste François Renaud.</p>
<p>(&#8230;)</p>
<p>On n’éradique pas un pathogène, on apprend à vivre avec. C’est un travail long et fastidieux, car chaque pathogène a un modus operandi qui lui est propre et qu’il faut découvrir. Pour ce faire, il faut comprendre la totalité des événements qui ont conduit à son émergence – sa niche écologique, les conditions de sa transmission… Cela demande une approche globale des épidémies dans toutes leurs composantes, biologiques, mais aussi environnementales et sociales. La santé publique, ce n’est pas seulement soigner les gens, c’est aussi faire en sorte qu’ils ne tombent pas malades.</p></blockquote>
<p>&nbsp;</p>
<h6>Retrouvez l&#8217;article complet : <a href="https://lejournal.cnrs.fr/articles/quand-lhomme-favorise-les-epidemies" target="_blank">https://lejournal.cnrs.fr/articles/quand-lhomme-favorise-les-epidemies</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=360</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Statement by MSF aid worker Dr. Craig Spencer</title>
		<link>http://www.ebolaweb.org/?p=337</link>
		<comments>http://www.ebolaweb.org/?p=337#comments</comments>
		<pubDate>Wed, 12 Nov 2014 17:11:17 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Africa]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Investigative journalism]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Craig Spencer]]></category>
		<category><![CDATA[Doctors Without Borders]]></category>
		<category><![CDATA[Médecins Sans Frontières]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=337</guid>
		<description><![CDATA[Published on MSF&#8217;s website, November 11, 2014 Hello, my name is Craig Spencer. I am a physician and aid worker for Doctors Without Borders, also known as MSF. I&#8217;m proud to be among the ranks of more than 3,300 Doctors Without Borders responding to the Ebola outbreak in West Africa. &#8230;]]></description>
				<content:encoded><![CDATA[<div class="field field-name-post-date field-type-ds field-label-hidden">
<div class="field-items">
<div class="field-item even"><a href="http://www.ebolaweb.org/wp-content/uploads/2014/10/logo.png"><img class="alignnone size-full wp-image-78" src="http://www.ebolaweb.org/wp-content/uploads/2014/10/logo.png" alt="logo" width="208" height="89" /></a></div>
<div class="field-item even"></div>
<div class="field-item even">Published on MSF&#8217;s website, November 11, 2014</div>
<div class="field-item even"></div>
</div>
</div>
<div class="field field-name-body field-type-text-with-summary field-label-hidden">
<div class="field-items">
<div class="field-item even">
<blockquote><p>Hello, my name is Craig Spencer. I am a physician and aid worker for Doctors Without Borders, also known as MSF. I&#8217;m proud to be among the ranks of more than 3,300 Doctors Without Borders responding to the Ebola outbreak in West Africa.</p>
<p>I wanted to start by taking a moment to thank the medical team here at HHC Bellevue Hospital Center for the tremendous care and support they have provided to me to survive this virus. Since I was admitted on October 23, I have received an exceptional level of medical treatment, support, and encouragement from the whole medical and administrative team. I would especially like to thank Dr. Laura Evans, who has primarily managed my care since I first arrived and has been with me every day. Today I am healthy and no longer infectious.</p>
<p>My recovery from Ebola speaks to the effectiveness of the protocols in place for health staff returning from West Africa at the time of my infection. I am a living example of how those protocols work, and of how early detection and isolation is critical to both surviving Ebola and ensuring that it is not transmitted to others.</p>
<p>While my case has garnered international attention, it is important to remember​ that my infection represents but a fraction of the more than 13,000 reported cases to date in West Africa—the center of the outbreak, where families are being torn apart and communities destroyed.</p></blockquote>
<p>&nbsp;</p>
<h6>Read the full article</h6>
<h6><a href="http://www.msf.org/article/statement-msf-aid-worker-dr-craig-spencer" target="_blank">http://www.msf.org/article/statement-msf-aid-worker-dr-craig-spencer</a></h6>
</div>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=337</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ebola compared to others infectious diseases</title>
		<link>http://www.ebolaweb.org/?p=272</link>
		<comments>http://www.ebolaweb.org/?p=272#comments</comments>
		<pubDate>Fri, 24 Oct 2014 13:44:15 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[Investigative journalism]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Visual]]></category>
		<category><![CDATA[infectious diseases]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=272</guid>
		<description><![CDATA[Clever &#8220;Microbe-scope&#8221; chart http://www.theguardian.com/news/datablog/ng-interactive/2014/oct/15/visualised-how-ebola-compares-to-other-infectious-diseases Google Document https://docs.google.com/spreadsheets/d/1kHCEWY-d9HXlWrft9jjRQ2xf6WHQlmwyrXel6wjxkW8/edit#gid=0]]></description>
				<content:encoded><![CDATA[<h6>Clever &#8220;Microbe-scope&#8221; chart</h6>
<h6><a href="http://www.theguardian.com/news/datablog/ng-interactive/2014/oct/15/visualised-how-ebola-compares-to-other-infectious-diseases" target="_blank">http://www.theguardian.com/news/datablog/ng-interactive/2014/oct/15/visualised-how-ebola-compares-to-other-infectious-diseases</a></h6>
<h6></h6>
<h6>Google Document</h6>
<h6><a href="https://docs.google.com/spreadsheets/d/1kHCEWY-d9HXlWrft9jjRQ2xf6WHQlmwyrXel6wjxkW8/edit#gid=0" target="_blank">https://docs.google.com/spreadsheets/d/1kHCEWY-d9HXlWrft9jjRQ2xf6WHQlmwyrXel6wjxkW8/edit#gid=0</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=272</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Somatosphere&#8217;s Web Roundup: Ebola Update</title>
		<link>http://www.ebolaweb.org/?p=260</link>
		<comments>http://www.ebolaweb.org/?p=260#comments</comments>
		<pubDate>Fri, 24 Oct 2014 11:29:48 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Investigative journalism]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[RDC]]></category>
		<category><![CDATA[Senegal]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[Spain]]></category>
		<category><![CDATA[Working papers]]></category>
		<category><![CDATA[Ebola fieldnotes]]></category>
		<category><![CDATA[Somatosphere]]></category>
		<category><![CDATA[Web Roundup]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=260</guid>
		<description><![CDATA[By Sara M Bergstresser This article is part of the series: Ebola fieldnotes &#160; A great deal has happened since the first Web Roundup on Ebola. The epidemic has spread both in West Africa and globally, and material about Ebola has spread throughout the web. According to the CDC, as &#8230;]]></description>
				<content:encoded><![CDATA[<p>By <a class="url fn" title="Posts by Sara M Bergstresser" href="http://somatosphere.net/author/sara-bergstresser" rel="author">Sara M Bergstresser</a></p>
<header class="entry-header">
<div class="series">This article is part of the series: <a href="http://somatosphere.net/series/ebola-fieldnotes" rel="tag">Ebola fieldnotes</a></div>
</header>
<div class="entry-content">
<p>&nbsp;</p>
<blockquote><p>A great deal has happened since <a title="Web Roundup: Ebola" href="http://somatosphere.net/2014/08/web-roundup-ebola.html">the first Web Roundup on Ebola</a>. The epidemic has spread both in West Africa and globally, and material about Ebola has spread throughout the web. <a title="CDC case counts" href="http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html">According to the CDC</a>, as of October 22, a total of 9911 cases of Ebola have been reported, primarily in Liberia, Guinea, and Sierra Leone (<a title="New Cases" href="http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-virus-outbreak-qa.html?smid=pl-share#outbreak-map">map of new cases</a>), and there have been an estimated 4546 deaths. WHO has declared an end to the outbreak in <a title="WHO Nigeria news" href="http://www.who.int/mediacentre/news/statements/2014/nigeria-ends-ebola/en/">Nigeria</a> and <a title="WHO Senegal news" href="http://www.who.int/mediacentre/news/statements/2014/senegal-ends-ebola/en/">Senegal</a>, but there are now cases in <a title="Cases outside Africa" href="http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-virus-outbreak-qa.html?emc=eta1&amp;_r=0#outside-africa">Europe and North America</a>. In Spain and the United States, there have been local cases of viral transmission within healthcare facilities.</p></blockquote>
</div>
<h6>Full article</h6>
<h6><a href="http://somatosphere.net/2014/10/web-roundup-ebola-update.html" target="_blank">http://somatosphere.net/2014/10/web-roundup-ebola-update.html</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=260</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ebola vaccine trials raise ethical issues</title>
		<link>http://www.ebolaweb.org/?p=173</link>
		<comments>http://www.ebolaweb.org/?p=173#comments</comments>
		<pubDate>Thu, 23 Oct 2014 17:37:25 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[English]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Liberia]]></category>
		<category><![CDATA[Peer reviewed]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[Doctors Without Borders]]></category>
		<category><![CDATA[Ethic]]></category>
		<category><![CDATA[ethical issues]]></category>
		<category><![CDATA[Jon Cohen]]></category>
		<category><![CDATA[Kai Kupferschmidt]]></category>
		<category><![CDATA[vaccine trials]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=173</guid>
		<description><![CDATA[The Ebola virus keeps spreading in West Africa and some researchers say that a vaccine is necessary to halt the epidemic. The two most advanced candidates have recently entered safety trials, and if they do not cause harm and trigger the immune response scientists hope to see, the World Health &#8230;]]></description>
				<content:encoded><![CDATA[<div class="article     summary-view     nonresearch-content">
<div id="abstract-2" class="section summary">
<blockquote>
<p id="p-2">The Ebola virus keeps spreading in West Africa and some researchers say that a vaccine is necessary to halt the epidemic. The two most advanced candidates have recently entered safety trials, and if they do not cause harm and trigger the immune response scientists hope to see, the World Health Organization (WHO) has recommended jumping straight into what amount to phase III efficacy tests in Liberia, Guinea, and Sierra Leone. But difficult questions are now emerging about how to design clinical trials, who should be the first to get the shots, and when to begin mass production. For instance, at a consultation held by WHO, there was broad support for randomized controlled trials. But some, like Doctors Without Borders, say such a trial, in which some subjects are assigned to a control group that doesn&#8217;t receive the actual vaccine, is unethical.</p>
</blockquote>
</div>
</div>
<div id="relmgr-related"><span class="name">By <a class="name-search" href="http://www.sciencemag.org/search?author1=Jon+Cohen&amp;sortspec=date&amp;submit=Submit">Jon Cohen</a> </span>&amp; <a class="name-search" href="http://www.sciencemag.org/search?author1=Kai+Kupferschmidt&amp;sortspec=date&amp;submit=Submit">Kai Kupferschmidt</a></div>
<p><abbr class="slug-jnl-abbrev" title="Science">Science</abbr><span class="slug-pub-date"> 17 October 2014: </span><br />
<span class="slug-vol">Vol. 346 </span><span class="slug-issue">no. 6207 </span><span class="slug-pages">pp. 289-290 </span><br />
DOI: <span class="slug-doi" title="10.1126/science.346.6207.289">10.1126/science.346.6207.289</span></p>
<h6>Read the Full Text: <a href="http://www.sciencemag.org/content/346/6207/289.full" target="_blank">http://www.sciencemag.org/content/346/6207/289.full</a></h6>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=173</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Le nouveau « Monsieur Ebola » fait le point sur la recherche en France</title>
		<link>http://www.ebolaweb.org/?p=164</link>
		<comments>http://www.ebolaweb.org/?p=164#comments</comments>
		<pubDate>Thu, 23 Oct 2014 16:06:39 +0000</pubDate>
		<dc:creator><![CDATA[Nathanael Cretin]]></dc:creator>
				<category><![CDATA[Biology/Virology]]></category>
		<category><![CDATA[Biomedicine/Clinical]]></category>
		<category><![CDATA[Epidemiology & Public Health]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[French]]></category>
		<category><![CDATA[Guinea]]></category>
		<category><![CDATA[Politics & Economy]]></category>
		<category><![CDATA[Sierra Leone]]></category>
		<category><![CDATA[Society & Culture]]></category>
		<category><![CDATA[Aviesan]]></category>
		<category><![CDATA[candidats vaccins]]></category>
		<category><![CDATA[chaire Anthropologie et santé mondiale]]></category>
		<category><![CDATA[Cohorte de survivants]]></category>
		<category><![CDATA[Collège d’études mondiales]]></category>
		<category><![CDATA[d’Aviesan]]></category>
		<category><![CDATA[essai clinique]]></category>
		<category><![CDATA[Inserm]]></category>
		<category><![CDATA[Jean-François Delfraissy]]></category>
		<category><![CDATA[lavimudine]]></category>
		<category><![CDATA[lefavipiravir]]></category>
		<category><![CDATA[rumeurs]]></category>
		<category><![CDATA[test de dépistage rapide]]></category>
		<category><![CDATA[Vinh-Kim Nguyen]]></category>

		<guid isPermaLink="false">http://www.ebolaweb.org/?p=164</guid>
		<description><![CDATA[Le 21/20/2014, par Damien Coulomb, sur http://www.lequotidiendumedecin.fr/ Le Pr Jean-François Delfraissy, directeur de l’Institut de microbiologie et maladies infectieuses (IMMI), vient d’être nommé par le Premier ministre Manuel Valls « coordinateur de l’ensemble des opérations internationales et nationales de réponse » à la crise Ebola. En compagnie d’Yves Lévy, président d’Aviesan et PDG de l’INSERM, il fait &#8230;]]></description>
				<content:encoded><![CDATA[<div class="ClearB">Le 21/20/2014, par <span data-scayt_word="Damien" data-scaytid="122">Damien</span> Coulomb, sur <a href="http://www.lequotidiendumedecin.fr/" target="_blank">http://www.lequotidiendumedecin.fr/</a></div>
<p class="ClearB">
<blockquote>
<p class="TX">Le <span data-scayt_word="Pr" data-scaytid="1">Pr</span> <span data-scayt_word="Jean-François" data-scaytid="2">Jean-François </span><span data-scayt_word="Delfraissy" data-scaytid="3">Delfraissy</span>, directeur de l’Institut de <span data-scayt_word="microbiologie" data-scaytid="4">microbiologie</span> et maladies infectieuses (<span data-scayt_word="IMMI" data-scaytid="5">IMMI</span>), vient d’être nommé par le Premier ministre Manuel <span data-scayt_word="Valls" data-scaytid="6">Valls</span> « <span data-scayt_word="coordinateur" data-scaytid="7">coordinateur </span>de l’ensemble des opérations internationales et nationales de réponse » à la crise <span data-scayt_word="Ebola" data-scaytid="8">Ebola</span>.<br />
En compagnie <span data-scayt_word="d’Yves" data-scaytid="9">d’Yves</span> <span data-scayt_word="Lévy" data-scaytid="10">Lévy</span>, président <span data-scayt_word="d’Aviesan" data-scaytid="11">d’Aviesan</span> et PDG de <span data-scayt_word="l’INSERM" data-scaytid="12">l’INSERM</span>, il fait le point sur les <a href="http://www.lequotidiendumedecin.fr/actualite/sante-publique/ebola-la-recherche-d-urgence-s-organise-en-france" target="_blank">projets menés par les organismes de recherche français</a> avec notamment la présentation d’un nouveau test diagnostic qui permet la détection d’une charge virale en 15 minutes.</p>
</blockquote>
<p class="TX">Points saillants :</p>
<h3 class="IN">Un test rapide de détection</h3>
<h3 class="IN">L’essai en <span data-scayt_word="Guinée" data-scaytid="23">Guinée</span> se précise</h3>
<h3 class="IN">Comprendre les populations locales</h3>
<h3 class="IN">Cohorte de survivants</h3>
<div class="EN">
<h3 class="TX"><strong>Essais cliniques en cascade pour les deux candidats vaccins</strong></h3>
<p>&nbsp;</p>
</div>
<p class="SI">Article complet : <a href="http://www.lequotidiendumedecin.fr/actualite/recherche-sciences/le-nouveau-monsieur-ebola-fait-le-point-sur-la-recherche-en-france" target="_blank">http://www.lequotidiendumedecin.fr/actualite/recherche-sciences/le-nouveau-monsieur-ebola-fait-le-point-sur-la-recherche-en-france</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ebolaweb.org/?feed=rss2&#038;p=164</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
